Geron Halts Late-Stage Blood Cancer Drug Study
Geron has halted a late-stage study of a drug for blood cancer, Reuters reports.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.